» Articles » PMID: 12679018

Discovery of a Novel Family of CDK Inhibitors with the Program LIDAEUS: Structural Basis for Ligand-induced Disordering of the Activation Loop

Abstract

A family of 4-heteroaryl-2-amino-pyrimidine CDK2 inhibitor lead compounds was discovered with the new database-mining program LIDAEUS through in silico screening. Four compounds with IC(50) values ranging from 17 to 0.9 microM were selected for X-ray crystal analysis. Two distinct binding modes are observed, one of which resembles the hydrogen bonding pattern of bound ATP. In the second binding mode, the ligands trigger a conformational change in the activation T loop by inducing movement of Lys(33) and Asp(145) side chains. The family of molecules discovered provides an excellent starting point for the design and synthesis of tight binding inhibitors, which may lead to a new class of antiproliferative drugs.

Citing Articles

Combined Physics- and Machine-Learning-Based Method to Identify Druggable Binding Sites Using SILCS-Hotspots.

Nordquist E, Zhao M, Kumar A, MacKerell Jr A J Chem Inf Model. 2024; 64(19):7743-7757.

PMID: 39283165 PMC: 11473228. DOI: 10.1021/acs.jcim.4c01189.


An Assessment of Dispersion-Corrected DFT Methods for Modeling Nonbonded Interactions in Protein Kinase Inhibitor Complexes.

Zhu Y, Alqahtani S, Hu X Molecules. 2024; 29(2).

PMID: 38257217 PMC: 11154270. DOI: 10.3390/molecules29020304.


Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action.

Lukasik P, Baranowska-Bosiacka I, Kulczycka K, Gutowska I Int J Mol Sci. 2021; 22(6).

PMID: 33802080 PMC: 8001317. DOI: 10.3390/ijms22062806.


Structure of cyclin-dependent kinase 2 (CDK2) in complex with the specific and potent inhibitor CVT-313.

Talapati S, Nataraj V, Pothuganti M, Gore S, Ramachandra M, Antony T Acta Crystallogr F Struct Biol Commun. 2020; 76(Pt 8):350-356.

PMID: 32744246 PMC: 7397463. DOI: 10.1107/S2053230X20009243.


Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer.

Frame S, Saladino C, MacKay C, Atrash B, Sheldrake P, McDonald E PLoS One. 2020; 15(7):e0234103.

PMID: 32645016 PMC: 7347136. DOI: 10.1371/journal.pone.0234103.